BlackRock Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
$9M Buy
48,907
+12,580
+35% +$2.32M 0.01% 1183
2016
Q3
$9.36M Sell
36,327
-1,904
-5% -$491K 0.01% 1046
2016
Q2
$8.16M Sell
38,231
-5,321
-12% -$1.14M 0.01% 1078
2016
Q1
$8.98M Buy
43,552
+1,094
+3% +$226K 0.01% 989
2015
Q4
$10.7M Buy
42,458
+562
+1% +$142K 0.01% 898
2015
Q3
$6.89M Buy
41,896
+3,342
+9% +$549K 0.01% 1154
2015
Q2
$7.24M Buy
38,554
+13,626
+55% +$2.56M 0.01% 1218
2015
Q1
$4.11M Buy
24,928
+115
+0.5% +$19K 0.01% 1517
2014
Q4
$5.77M Buy
24,813
+72
+0.3% +$16.7K 0.01% 1262
2014
Q3
$4.48M Buy
24,741
+155
+0.6% +$28.1K 0.01% 1405
2014
Q2
$4.73M Sell
24,586
-85
-0.3% -$16.3K 0.01% 1422
2014
Q1
$4.49M Buy
24,671
+1,971
+9% +$358K 0.01% 1440
2013
Q4
$3.87M Sell
22,700
-542
-2% -$92.3K 0.01% 1525
2013
Q3
$3.64M Buy
23,242
+896
+4% +$140K 0.01% 1496
2013
Q2
$3.87M Buy
+22,346
New +$3.87M 0.01% 1390